|Written by Rob Goldman|
The month of August scares the hell out of me. It’s like a freakin’ horror movie as the declines have been brutal In fact, if you go back 20 years, the monthly declines range from 5% - 14%!! Still, we have uncovered a fallen angel priced to move higher later this month.
AUGUST: STOCKS’ HORROR MOVIE
The month of August scares the hell out of me. It’s like a freakin’ horror movie. Since 2000, the index has risen 10 times and dropped 6 times. But the declines have been brutal while the gains have been tame. In fact, excluding the big 2000 August rise, the month has averaged only 1.7% when it lean to the positive side. It is even uglier if you go back 20 years, where the average decline is 5.5% and the gains average just 2.2%. And the monthly declines range from 5% - 14%!!
I can’t explain it but bad shit just seems to happen politically, economically, etc. in the month of August. Moreover, we tend to have a dearth of market-related news to carry stocks ahead, too. Europe essentially shuts down in the second half of the month. After August 15th, we don’t really have much of an earnings season left so companies that have been buoyed by earnings will see that momentum deteriorate.Reviewing statistics going back 20 years is also very instructive, especially since we are coming off a tremendous July performance. Not only did the S&P 500 Index rise by 3.5% but the Russell 2000 Index jumped by 6%! It is now (as we have been hammering home for months) the best performing of the key indices, on a year-to-date basis. This is all well and good. However, there is a slight negative bias in the month of August following a strong July, whereby the market has experienced a decline of 3-6%. This is our concern.
The Stock Market Today
Perhaps a big drop of this magnitude is not in the cards. Still, we proffer that stocks are more likely to decline than rise this month. They just need a little breather, as we head into the wacky September/October period.
I must confess that for the past week or so I have had a lot of difficulty picking new stocks. So many, especially in the small cap and microcap arenas have made big moves from those recent, post-Brexit June lows. Granted, they look great technically, but do you really want to buy something after it has made a big move to the upside? In fact, that is one of the reasons why we played it safe and different in the latest 30-30 Report by profiling stocks that are beaten down but are due to make a move.
One stock that could make such a move is Marchex (NASDAQ—MCHX—$3.17—NR.) Here’s what you need to know about this mobile provider of call analytics and display analytics for marketers and small businesses, along with local leads. The stock is down almost 19% year-to-date and somehow has broken above its 20-DMA as of last week. Its second quarter results will be released on August 9th, and we believe that the stock, over 70%-owned by institutions, could bounce ahead of and following the results. Given our less than sanguine view of stocks later this month, we approach this profile as a trade only, and caution that doing so ahead of earnings carries considerable risk along with major reward, if the Q and outlook are solid.
Great info, insights, and hard-hitting stories make up this week’s Say What? feature...
The New York Post
As Mr. Spock would say, fascinating
Yes but what about after...
It’s a new age out there, folks.
A helluva cover story.
We all know the corruption here. But, will it actually impact anything is the question.
AAII Sentiment Survey (figures rounded)
Can you feel the enthusiasm being tempered even as we hit new highs in key indices? Interestingly, while we have incrementally more Neutrals and Bears we also have more folks in the correction camp by a smidgen—according to Investors Intelligence. Four out of the last five weeks have witnessed equity outflows (according to Lipper) including the past 2 weeks. Could be a tell...
1498 Reisterstown Road, Suite 286 Baltimore Maryland 21208 Phone: 410.609.7100
[email protected] www.goldmanresearch.com
Launched in May 2010, The Goldman Guide is a free weekly publication of Goldman Small Cap Research and is written by Founder Rob Goldman with contributions from the GSCR contributor team. This non-sponsored investment newsletter seeks to provide investors with market, economic, political and equity-specific insights via an action-oriented, straight to the point approach. No companies mentioned in this newsletter are current sponsored research clients of the Company or its parent, unless noted, With some exceptions, all companies or investment ideas mentioned in this publication are publicly traded stocks listed either on the NYSE or the NASDAQ. Goldman Small Cap Research members and contributors’ bios, certifications, and experience can be found on our website: www.goldmanresearch.com
This newsletter was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces non-sponsored and sponsored (paid) investment research. Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.
The Firm’s non-sponsored research publications category, Select Research, reflects the Firm’s internally generated stock ideas, along with economic, industry and market outlooks. In virtually all cases, stocks mentioned in Select Research offerings are listed on the NYSE or the NASDAQ. Publications in this category include the weekly newsletter The Goldman Guide, Market Monitor blogs, Special Reports, and premium products such as The 30-30 Report. Goldman Small Cap Research analysts are neither long nor short stocks mentioned in this newsletter.
Opportunity Research reports, updates and Microcap Hot Topics articles reflect sponsored (paid) research but can also include non-sponsored microcap research ideas that typically carry greater risks than those stocks covered in Select Research category. It is important to note that while we may track performance separately, we utilize many of the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in company-specific Opportunity Research reports, updates and articles.
Goldman Small Cap Research has not been compensated for any content in this issue.
All information contained in this newsletter and in our reports were provided by the companies mentioned via news releases, filings, and their websites or generated from our own due diligence. Economic, market data and charts are provided by a variety of sources and are cited upon publication. Stock performance data and information are derived from Yahoo! Finance and other websites or sources, as noted. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, other firms, or other financial news outlets. Goldman Small Cap Research relied solely upon information provided by companies through filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report, update, article, blog, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. This newsletter does not take into account the investment objectives, financial situation, or particular needs of any particular person. This newsletter does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with the FINRA or with any state securities regulatory authority. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.
Separate from the factual content of our articles about the company featured in this newsletter, we may from time to time include our own opinions about the companies profiled herein, their businesses, markets and opportunities. Any opinions we may offer about the companies are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Such information and the opinions expressed are subject to change without notice.
ALL INFORMATION IN THIS REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com.